Clinical Outcomes in Patients With COVID-19 and Hematologic Disease-Reference-Cited by-同舟云学术

Clinical Outcomes in Patients With COVID-19 and Hematologic Disease

Published:2023-08 Issue:8 Volume:23 Page:589-598
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Aleshina Olga A.^ORCID,Zakurdaeva Kristina^ORCID,Vasileva Anastasia N.^ORCID,Dubov Sergey K.,Dubov Vitaly S.,Vorobyev Vladimir I.^ORCID,Butaev Lev S.^ORCID,Sukhareva Alena M.^ORCID,Gavrilova Lubov V.,Toropova Inessa Yu.,Popova Marina O.^ORCID,Siniaev Aleksandr A.^ORCID,Kulagin Aleksandr D.^ORCID,Kaplanov Kamil D.^ORCID,Petrenko Andrei A.^ORCID,Ochirova Oksana I.,Karpova Alina,Chelysheva Ekaterina Yu.,Turkina Anna G.^ORCID,Gurianova Margarita A.^ORCID,Al-Radi Liubov S.,Gilyazitdinova Elena A.,Egorova Elena K.^ORCID,Chabaeva Yulia A.^ORCID,Kulikov Sergey M.^ORCID,Sveshnikova Yulia V.^ORCID,Kunst Mikhail A.^ORCID,Shuvaev Vasily^ORCID,Rakhmani Anzhelika F.,Panteleeva Olga L.,Grishunina Maria E.^ORCID,Samoylova Olga S.,Vorontsova Ekaterina,Baryshnikova Daria V.^ORCID,Parovichnikova Elena N.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference31 articles.

1. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak;Dai;Cancer Discov,2020

2. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang;Lancet Oncol,2020

3. Chemotherapy and COVID-19 outcomes in patients with cancer;Jee;J Clin Oncol,2020

4. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study;Kuderer;Lancet,2020

5. COVID-19 severity and outcomes in patients with cancer: a matched cohort study;Brar;J Clin Oncol,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematological Conditions Associated with COVID-19: Pathophysiology, Clinical Manifestations, and Therapeutic Approaches;European Journal of Medical and Health Research;2024-09-01

2. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination;Russian journal of hematology and transfusiology;2024-08-18

3. Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network—The VISAGE Study;Vaccines;2024-06-07

4. Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis;Revista da Associação Médica Brasileira;2024

5. The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic;Terapevticheskii arkhiv;2023-10-11